Mostrar el registro sencillo del ítem

dc.contributor.authorBobi, Joaquim
dc.contributor.authorSolanes, Nuria
dc.contributor.authorFernandez-Jimenez, Rodrigo 
dc.contributor.authorGalan-Arriola, Carlos 
dc.contributor.authorDantas, Ana Paula
dc.contributor.authorFernandez-Friera, Leticia 
dc.contributor.authorGalvez-Monton, Carolina
dc.contributor.authorRigol-Monzo, Elisabet
dc.contributor.authorAguero, Jaume 
dc.contributor.authorRamirez, Jose
dc.contributor.authorRoque, Merce
dc.contributor.authorBayes-Genis, Antoni
dc.contributor.authorSanchez-Gonzalez, Javier 
dc.contributor.authorGarcia-Alvarez, Ana 
dc.contributor.authorSabaté, Manel
dc.contributor.authorRoura, Santiago
dc.contributor.authorIbáñez, Borja 
dc.contributor.authorRigol, Montserrat
dc.date.accessioned2017-10-20T10:23:12Z
dc.date.available2017-10-20T10:23:12Z
dc.date.issued2017
dc.identifierISI:000404098600058
dc.identifier.citationJ Am Heart Assoc. 2017; 6(5):e005771
dc.identifier.issn2047-9980
dc.identifier.urihttp://hdl.handle.net/20.500.12105/5119
dc.description.abstractBackground-Autologous adipose tissue-derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post-myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long-term effects and the mechanisms involved in allogeneic ATMSCs administration on myocardial performance. Methods and Results-Thirty-eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic ATMSCs or culture medium (vehicle) were intracoronarily administered. Follow-ups were performed at short (2 days after acute myocardial infarction vehicle-treated, n=10; ATMSCs-treated, n=9) or long term (60 days after acute myocardial infarction vehicle-treated, n=7; ATMSCs-treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the ATMSCs-treated animals (48.6 +/- 6\% versus 55.9 +/- 5.7\% in vehicle; P=0.017); enhancement of the reparative process with up-regulated vascular endothelial growth factor, granulocyte macrophage colony-stimulating factor, and stromal-derived factor-1 alpha gene expression; and increased M2 macrophages (67.2 +/- 10\% versus 54.7 +/- 10.2\% in vehicle; P=0.016). In long-term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day-7 and day-60 cardiac magnetic resonance studies in ATMSCs-treated animals, compared to vehicle (87.9 +/- 28.7 versus 57.4 +/- 17.7 mL/min per gram at 7 days; P=0.034 and 99 +/- 22.6 versus 43.3 +/- 14.7 22.6 mL/min per gram at 60 days; P=0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the ATMSCs-treated animals (118 +/- 18 versus 92.4 +/- 24.3 vessels/mm(2) in vehicle; P=0.045). Cardiac magnetic resonance-measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. Conclusions-In this porcine acute myocardial infarction model, allogeneic ATMSCs-based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance-measured perfusion. No effect on left ventricular volumes or ejection fraction was observed.
dc.description.sponsorshipThis work was supported by grants from Fundacion la Marato de TV3 (122230); Fondo de Investigacion Sanitaria Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FIS PI14/01682), (RD12/0042/0006), (RD12/0042/0047), (RD12/0019/0029) (TerCel RD16/0011/0006), CIBER Cardiovascular (CB16/11/00403) projects and Ministerio de Educacion y Ciencia (SAF2011-30067-C02-01) (SAF2014-59892). Fernaandez-Jimenez was the recipient of nonoverlapping grants from the Ministerio de Economia, Industria, y Competitividad through the Instituto de Salud Carlos III (Rio Hortega fellowship); and the Fundacion Jesus Serra, the Fundacion Interhospitalaria de Investigacion Cardiovascular (FIC), and the CNIC (FICNIC fellowship). The use of QMass software was partly supported by a scientific collaboration between the CNIC and Medis Medical Imaging Systems BV. The CNIC is supported by the Ministerio de Economia, Industria, y Competitividad (MINECO) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). This work was also funded by ``la Caixa Banking Foundation, and the Generalitat de Catalunya (SGR 2014, CERCA Programme). This work has been developed in the context of AdvanceCat with the support of ACCIO (Catalonia Trade \& Investment; Generalitat de Catalunya) under the Catalonian ERDF operational program (European Regional Development Fund) 2014-2020.
dc.language.isoeng
dc.publisherWiley 
dc.type.hasVersionVoR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectadipose tissue-derived mesenchymal stem cells
dc.subjectallogeneic origin
dc.subjectmyocardial infarction
dc.subjectmyocardial perfusion
dc.subjectvascular density
dc.subjectRANDOMIZED PHASE-1 TRIAL
dc.subjectCARDIAC-FUNCTION
dc.subjectISCHEMIC CARDIOMYOPATHY
dc.subjectPROMOTE ANGIOGENESIS
dc.subjectPROGENITOR CELLS
dc.subjectHEART-FAILURE
dc.subjectPORCINE MODEL
dc.subjectDISEASE
dc.subjectTHERAPY
dc.subjectISCHEMIA/REPERFUSION
dc.titleIntracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
dc.typejournal article
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID28468789
dc.format.volume6
dc.identifier.doi10.1161/JAHA.117.005771
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderMinisterio de Educación y Ciencia (España) 
dc.contributor.funderFundación Jesús Serra 
dc.contributor.funderFundación Interhospitalaria de Investigación Cardiovascular 
dc.contributor.funderMedis Medical Imaging 
dc.contributor.funderMinisterio de Economía, Industria y Competitividad (España) 
dc.contributor.funderFundación ProCNIC 
dc.contributor.funderFundación La Caixa 
dc.contributor.funderGovernment of Catalonia (España) 
dc.contributor.funderFundación La Marató TV3 
dc.description.peerreviewed
dc.relation.publisherversionhttps://doi.org/10.1161/JAHA.117.005771
dc.identifier.journalJournal of the American Heart Association
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovascular
dc.repisalud.institucionCNIC
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES6/SAF2014-59892es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEV-2015-0505es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI14/01682es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0042/0006es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0042/0047es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0019/0029es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16/0011/0006es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CB16/11/00403es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2011-30067-C02-01es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional